Interdisciplinary Working Group for Movement Disorders
Botulinum neurotoxin type A injections reduce spasticity in mild to moderate hereditary spastic paraplegia – Report of 19 cases: Hecht MJ et al.
Movement Disorders Vol. 23, No. 2, 2008, pp. 228–233
© 2007 Movement Disorder Society
© 2007 Movement Disorder Society
Authors
Martin J. Hecht, MD, 1,2*
Henning Stolze, MD, 3,4
Martin J. Hecht, MD, 1,2*
Henning Stolze, MD, 3,4
Matthias Auf dem Brinke, MD, 5
Ralf Giess, MD, 6
Thoams Treig, MD, 7,8
Martin Winterholler, MD, 9
and Joerg Wissel, MD, 10
for the German Spasticity Education Group
Author Details
1 Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany
2 Department of Neurology, BKH Kaufbeuren, Germany
3 Department of Neurology, University of Kiel, Kiel, Germany
4 Department of Neurology, Diako Hospital, Flensburg, Germany
5 Department of Neurological Rehabilitation, Bad Wildungen, Germany
6 Department of Neurology, Henriettenstiftung, Hannover, Germany
7 Neurological Rehabilitation Centre, Ernst-Moritz-Arndt University, Greifswald, Germany
8 Neurological Rehabilitation Centre, Schwarzwaldkliniken, Bad Krozingen, Germany
9 Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck, Germany
10 Department of Neurological Rehabilitation, Beelitz Heilsta¨tten, Beelitz, Germany
9 Department of Neurology, Rummelsberger Kliniken, Schwarzenbruck, Germany
10 Department of Neurological Rehabilitation, Beelitz Heilsta¨tten, Beelitz, Germany
Unsere Zertifizierer
